💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

DBV Technologies expands leadership team; shares up 14% premarket

Published 01/03/2019, 07:03 AM
© Reuters.  DBV Technologies expands leadership team; shares up 14% premarket
ALXN
-
DBVT
-
  • DBV Technologies (NASDAQ:DBVT) announces the following changes to its leadership team:
  • DBV's Chief Scientific Officer, Dr. Hugh Sampson, will assume the role of interim Chief Medical Officer effective today. Dr. Sampson succeeds Dr. Lucia Septien-Velez, who has decided to leave to pursue other opportunities. Dr. Sampson will lead both the scientific and medical teams and will report to Daniel Tassé, CEO.
  • Julie O'Neill, has been engaged effective immediately to direct all product development and process optimization at the Company. She will continue serving as a director, while overseeing the anticipated resubmission of the Viaskin Peanut BLA in children four to 11 years of age.
  • Most recently, Julie was Executive VP, Global Operations for Alexion Pharmaceuticals (NASDAQ:ALXN).
  • Alan Kerr, Senior VP, Head of Global Regulatory Affairs of DBV Technologies, will now report to the Company's CEO, Daniel Tassé, effective immediately.
  • Shares are up 14% premarket.
  • Now read: Aimmune Therapeutics: Keep Your Eyes Peeled


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.